Washington, DC 20006-5349
HELPLINE
The Mesothelioma Applied Research Foundation is proud to announce the recipients of its most recent round of new mesothelioma research funding. Through a rigorous review…
Today, the Mesothelioma Applied Research Foundation announced its 2022 mesothelioma award recipients for its Pioneer Award, the Klaus Brauch Above and Beyond Award, and the…
For over 18 years, the International Symposium on Malignant Mesothelioma has been the go-to place for mesothelioma patients and their families to find community and…
A new study just published in the journal Science challenged our collective hope that natural infection by Omicron would convey a degree of immunity that…
In an analysis published last week, the Centers for Disease Control and Prevention (CDC) reported a significant increase in mesothelioma deaths among women during the…
This week, the paper “Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations,” by Drs. Michele Carbone, Harvey Pass, and…
Data from a study comparing the efficacy of anetumab ravtansine, a monoclonal antibody conjugate, against vinorelbine showed no improvement in progression-free survival. The results of…
The Meso Foundation has joined together with hundreds of other rare disease advocacy organizations as part of Rare Disease Week 2022.Julie Powers, Meso Foundation Executive…
The field of radiology and imaging has relatively quickly advanced from simple x-rays that allow us to take a non-invasive, albeit limited, peek inside the…
As 2021 concludes and 2022 begins, we bring you mesothelioma treatment news directly from clinicians and researchers. Two newly published articles give us a useful…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
